Ghitza Udi E, Epstein David H, Schmittner John, Vahabzadeh Massoud, Lin Jia-Ling, Preston Kenzie L
Treatment Section, Clinical Pharmacology and Therapeutics Branch, Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), National Institute of Health (NIH), MD, USA.
J Consult Clin Psychol. 2007 Oct;75(5):765-74. doi: 10.1037/0022-006X.75.5.765.
To examine the effect of reinforcer density in prize-based abstinence reinforcement, heroin/cocaine users (N = 116) in methadone maintenance (100 mg/day) were randomly assigned to a noncontingent control group (NonC) or to 1 of 3 groups that earned prize draws for abstinence: manual drawing with standard prize density (MS) or computerized drawing with standard (CS) or high (CH) density. Probabilities (prizes/draw) were standard (50%) and high (78%); prize density was double blind. Mean prize values were CH, $286; CS, $167; MS, $139; and NonC, $171. Outcomes were % opioid/cocaine-negative urines during the 12-week intervention and then 8 weeks postintervention as well as diagnosis of dependence up to 6 months poststudy. CH had significantly more negative specimens than did NonC during intervention and had more than all groups during postintervention treatment: Mean % negative (95% confidence interval) during postintervention treatment adjusted for baseline drug use and dropout were CH, 55% (14%-90%); CS, 7% (1%-27%); MS, 4% (1%-12%); and NonC, 3% (1%-10%). Current cocaine dependence diagnoses after treatment were significantly lower in contingent compared with noncontingent groups. Computerized drawing with higher-density prizes enhanced reduction of cocaine use; abstinence reinforcement had long-term therapeutic benefits.
为研究基于奖励的戒断强化中强化物密度的影响,对接受美沙酮维持治疗(每日100毫克)的海洛因/可卡因使用者(N = 116)进行随机分组,分为非偶然对照组(NonC)或3个因戒断获得抽奖奖励的组之一:标准奖励密度的手动抽奖组(MS)或标准(CS)或高(CH)密度的计算机化抽奖组。概率(奖品/抽奖)为标准(50%)和高(78%);奖励密度为双盲。平均奖品价值为CH组286美元;CS组167美元;MS组139美元;NonC组171美元。观察指标为12周干预期间以及干预后8周的阿片类药物/可卡因阴性尿液百分比,以及研究后长达6个月的依赖诊断情况。在干预期间,CH组的阴性样本显著多于NonC组,在干预后治疗期间,CH组的阴性样本多于所有其他组:根据基线药物使用情况和失访情况调整后的干预后治疗期间平均阴性百分比(95%置信区间)为CH组55%(14%-90%);CS组7%(1%-27%);MS组4%(1%-12%);NonC组3%(1%-10%)。与非偶然组相比,偶然组治疗后当前可卡因依赖诊断显著更低。具有更高密度奖品的计算机化抽奖增强了可卡因使用的减少;戒断强化具有长期治疗益处。